Australian Trade Mark Search

Endorsements

Convention priority claimed: 08 June 2001, United States of America, No. 76/268750, in respect of MEDICAL AND SCIENTIFIC RESEARCH AND DEVELOPMENT SERVICES FOR THIRD PARTIES; MEDICAL AND SCIENTIFIC CONSULTING SERVICES FOR THIRD PARTIES; PROVIDING ACCESS TO DATABASES OF MEDICAL AND SCIENTIFIC INFORMATION in class 42, 15 June 2001, No. 76/272231, in respect of BIOTECHNOLOGICAL PRODUCTS, BEING PULP AND PAPER PROCESSING ENZYMES, NAMELY XYLANASE FOR BLEACH BOOSTING, PITCH REDUCTION LIPASES, CELLULASES FOR BLEACH BOOSTING; DETERGENT ENZYMES, NAMELY, DETERGENT PROTEASES, DETERGENT CELLULASES, DETERGENT LIPASES; WASTE REMEDIATION ENZYMES, NAMELY, DEHALOGENASE ENZYMES; BIOMASS PROCESSING ENZYMES, NAMELY, CELLULASES, AMYLASES, AND GLUCOAMYLASES in class 1, and 15 June 2001, No. 76/272229, in respect of PHARMACEUTICAL PREPARATIONS FOR HORMONE REPLACEMENT THERAPIES, NAMELY CANCER GENE THERAPY, DIABETES THERAPY, T-CELL THERAPY, BLOOD GROWTH FACTORS, NEURAL GROWTH FACTOR THERAPY, ANTI-COAGULANT THERAPY, BIOLOGICAL RESPONSE MODIFIER THERAPY, ANTI- CANCER ANTIBODY THERAPY, ANTI-VIRAL THERAPY, ANTI- MICROBIAL THERAPY; DRUG SCREENING REAGENTS, NAMELY CYTOKINE RECEPTOR ASSAY REAGENTS; AND HIGH THROUGHPUT ASSAYS in class 5.*

Convention details